‘Potential Game Changer’ for Psoriasis Gets Green Light From FDA
(MedPage Today) -- The FDA has approved the first oral interleukin (IL)-23-targeted therapy for plaque psoriasis, Johnson & Johnson announced. ...
(MedPage Today) -- The FDA has approved the first oral interleukin (IL)-23-targeted therapy for plaque psoriasis, Johnson & Johnson announced. ...
The argument for early reversal rests on longitudinal observations, which show that children who normalise their weight before entering late ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.